Olaplex (OLPX) Financials

$2.03 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$2.04 +0.01 (+0.25%)

As of 04:43 PM Eastern

Annual Income Statements for Olaplex

This table shows Olaplex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	39	221	244	62	20	-9.25
Consolidated Net Income / (Loss)	39	221	244	62	20	-9.25
Net Income / (Loss) Continuing Operations	39	221	244	62	20	-9.25
Total Pre-Tax Income	47	276	305	77	27	-6.18
Total Operating Income	86	334	364	108	67	6.95
Total Gross Profit	180	474	520	319	292	294
Total Revenue	282	598	704	458	423	423
Operating Revenue	282	598	704	458	423	423
Total Cost of Revenue	103	125	185	140	130	129
Operating Cost of Revenue	103	125	185	140	130	129
Total Operating Expenses	93	140	155	210	225	287
Selling, General & Admin Expense	37	99	114	169	182	243
Amortization Expense	40	41	41	41	44	44
Total Other Income / (Expense), net	-39	-59	-59	-32	-40	-13
Interest Expense	39	61	63	58	60	41
Interest & Investment Income	-	0.00	2.78	19	25	15
Other Income / (Expense), net	-0.19	2.60	0.83	7.62	-5.82	13
Income Tax Expense	7.98	55	61	15	7.39	3.08
Basic Earnings per Share	$0.06	$0.34	$0.38	$0.09	$0.03	($0.01)
Weighted Average Basic Shares Outstanding	635.39M	648.17M	649.09M	654.59M	661.98M	666.46M
Diluted Earnings per Share	$0.06	$0.32	$0.35	$0.09	$0.03	($0.01)
Weighted Average Diluted Shares Outstanding	636.82M	689.92M	691.01M	677.58M	665.40M	666.46M
Weighted Average Basic & Diluted Shares Outstanding	-	648.79M	651.90M	660.76M	664.62M	669.40M

This table shows Olaplex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	20	14	7.75	5.78	15	-8.80	0.47	-7.74	11	-13	-5.29
Consolidated Net Income / (Loss)	20	14	7.75	5.78	15	-8.80	0.47	-7.74	11	-13	-5.29
Net Income / (Loss) Continuing Operations	20	14	7.75	5.78	15	-8.80	0.47	-7.74	11	-13	-5.29
Total Pre-Tax Income	26	17	10	7.68	20	-11	0.88	-9.07	8.70	-6.69	-9.68
Total Operating Income	37	17	20	16	28	3.05	8.48	-1.20	4.18	-4.50	-5.11
Total Gross Profit	84	77	71	72	82	67	67	76	79	71	72
Total Revenue	124	112	99	104	119	101	97	106	115	105	99
Operating Revenue	124	112	99	104	119	101	97	106	115	105	99
Total Cost of Revenue	40	35	28	32	37	34	30	31	35	34	28
Operating Cost of Revenue	40	35	28	32	37	34	30	31	35	34	28
Total Operating Expenses	47	60	52	56	54	64	59	77	75	76	77
Selling, General & Admin Expense	36	49	40	45	43	53	48	66	64	65	66
Amortization Expense	10	10	11	11	11	11	11	11	11	11	11
Total Other Income / (Expense), net	-10	0.09	-9.25	-8.60	-8.34	-14	-7.60	-7.86	4.52	-2.19	-4.57
Interest Expense	15	15	15	15	16	15	14	12	7.69	7.55	7.13
Interest & Investment Income	5.18	5.80	6.20	6.26	6.61	6.31	5.95	3.53	2.69	2.66	2.70
Other Income / (Expense), net	-0.97	8.95	-0.95	-0.26	0.67	-5.28	0.18	0.99	9.52	2.70	-0.14
Income Tax Expense	5.89	3.15	2.62	1.90	4.86	-2.00	0.42	-1.32	-2.43	6.41	-4.40
Basic Earnings per Share	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)	$0.00	($0.01)	$0.02	($0.02)	($0.01)
Weighted Average Basic Shares Outstanding	654.70M	654.59M	660.82M	661.73M	662.25M	661.98M	664.69M	665.95M	667.07M	666.46M	669.94M
Diluted Earnings per Share	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)	$0.00	($0.01)	$0.02	($0.02)	($0.01)
Weighted Average Diluted Shares Outstanding	678.76M	677.58M	663.57M	663.55M	666.15M	665.40M	666.46M	665.95M	668.86M	666.46M	669.94M
Weighted Average Basic & Diluted Shares Outstanding	654.73M	660.76M	661.76M	661.98M	662.92M	664.62M	665.92M	667.08M	667.51M	669.40M	672.04M

This table details how cash moves in and out of Olaplex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	11	175	136	144	120	-267
Net Cash From Operating Activities	129	200	255	178	143	59
Net Cash From Continuing Operating Activities	129	200	255	178	143	59
Net Income / (Loss) Continuing Operations	39	221	244	62	20	-9.25
Consolidated Net Income / (Loss)	39	221	244	62	20	-9.25
Depreciation Expense	0.00	0.16	0.36	0.48	0.49	0.35
Amortization Expense	92	52	50	52	55	57
Non-Cash Adjustments To Reconcile Net Income	1.53	3.96	35	25	22	30
Changes in Operating Assets and Liabilities, net	-4.18	-76	-74	38	46	-20
Net Cash From Investing Activities	-1,382	-6.27	-2.68	-3.61	-4.89	-13
Net Cash From Continuing Investing Activities	-1,382	-6.27	-2.68	-3.61	-4.89	-13
Purchase of Property, Plant & Equipment	-0.03	-0.88	-0.65	-0.38	-1.12	-0.33
Acquisitions	-1,382	-0.89	-2.03	-3.24	-3.77	-12
Net Cash From Financing Activities	1,264	-18	-116	-30	-19	-313
Net Cash From Continuing Financing Activities	1,264	-18	-116	-30	-19	-313
Repayment of Debt	-76	-20	-792	-8.44	-6.75	-302
Other Financing Activities, net	0.00	1.14	1.10	-22	-12	-12
Cash Interest Paid	35	58	41	60	60	34
Cash Income Taxes Paid	9.91	34	60	7.74	12	-0.09

This table details how cash moves in and out of Olaplex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	51	37	41	0.42	31	47	-5.07	-292	-2.96	32	7.44
Net Cash From Operating Activities	53	49	44	16	33	50	-2.92	21	8.00	33	7.50
Net Cash From Continuing Operating Activities	53	49	44	16	33	50	-2.92	21	8.00	33	7.50
Net Income / (Loss) Continuing Operations	20	14	7.75	5.78	15	-8.80	0.47	-7.74	11	-13	-5.29
Consolidated Net Income / (Loss)	20	14	7.75	5.78	15	-8.80	0.47	-7.74	11	-13	-5.29
Depreciation Expense	0.11	0.14	0.15	0.14	0.11	0.09	0.09	0.09	0.09	0.08	0.08
Amortization Expense	13	13	14	13	14	14	14	16	14	14	14
Non-Cash Adjustments To Reconcile Net Income	6.59	7.43	4.31	4.88	4.10	9.20	4.29	5.54	14	6.57	4.33
Changes in Operating Assets and Liabilities, net	13	14	18	-8.04	0.65	36	-21	7.04	-31	25	-5.15
Net Cash From Investing Activities	-0.91	-0.71	-1.08	-1.09	-1.19	-1.52	-1.00	-0.33	-11	-0.32	-0.29
Net Cash From Continuing Investing Activities	-0.91	-0.71	-1.08	-1.09	-1.19	-1.52	-1.00	-0.33	-11	-0.32	-0.29
Purchase of Property, Plant & Equipment	-0.11	-0.14	-0.45	-0.11	-0.13	-0.43	-0.05	-0.10	-0.07	-0.11	-0.15
Acquisitions	-0.80	-0.58	-0.63	-0.99	-1.06	-1.09	-0.95	-0.23	-11	-0.21	-0.14
Net Cash From Financing Activities	-1.34	-12	-1.52	-15	-1.37	-1.00	-1.16	-312	-	-	0.23
Net Cash From Continuing Financing Activities	-1.34	-12	-1.52	-15	-1.37	-1.00	-1.16	-312	-	-	0.23
Repayment of Debt	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69	-300	-	-	0.00
Other Financing Activities, net	0.35	-9.82	0.17	-13	0.32	0.69	0.53	-12	-	-	0.23
Cash Interest Paid	15	15	15	10	21	14	13	6.87	7.24	7.11	6.78
Cash Income Taxes Paid	0.02	-1.79	5.00	5.56	2.08	-0.26	0.62	-0.40	0.02	-0.32	-2.91

This table presents Olaplex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,333	1,560	1,698	1,740	1,768	1,497
Total Current Assets	61	335	522	613	690	470
Cash & Equivalents	11	186	323	466	586	319
Accounts Receivable	14	41	46	41	15	29
Inventories, net	34	98	144	96	75	60
Prepaid Expenses	-	-	-	9.95	14	62
Plant, Property, & Equipment, net	0.03	0.75	1.03	0.93	1.44	1.42
Total Noncurrent Assets	1,271	1,224	1,174	1,126	1,077	1,026
Goodwill	168	168	168	168	168	168
Intangible Assets	1,092	1,043	995	948	900	848
Noncurrent Deferred & Refundable Income Taxes	11	8.34	-	-	0.00	0.05
Other Noncurrent Operating Assets	-	4.50	11	10	8.72	9.55
Total Liabilities & Shareholders' Equity	1,333	1,560	1,698	1,740	1,768	1,497
Total Liabilities	802	1,036	917	895	893	618
Total Current Liabilities	47	73	55	56	65	103
Accounts Payable	17	23	9.75	7.07	10	8.12
Accrued Expenses	9.86	17	17	30	36	85
Other Current Liabilities	-	-	16	-	-	9.21
Total Noncurrent Liabilities	755	963	862	839	829	515
Long-Term Debt	755	738	654	649	644	352
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.00	1.62	3.02	5.16	5.28
Other Noncurrent Operating Liabilities	-	-	206	187	180	158
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	531	524	781	845	874	879
Total Preferred & Common Equity	531	524	781	845	874	879
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	531	524	781	845	874	879
Common Stock	531	304	314	317	329	343
Retained Earnings	0.00	221	465	526	546	537
Accumulated Other Comprehensive Income / (Loss)	-	0.00	2.58	1.37	-0.77	-0.34

This table presents Olaplex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	1,697	1,726	1,723	1,742	1,753	1,757	1,759	1,771	1,517	1,514	1,460
Total Current Assets	497	564	571	601	639	654	670	704	463	473	446
Cash & Equivalents	249	369	378	430	508	508	539	581	289	286	326
Accounts Receivable	93	46	50	52	26	34	35	24	33	50	38
Inventories, net	151	132	129	113	95	100	86	79	78	73	66
Prepaid Expenses	-	-	-	-	-	-	-	20	62	64	16
Plant, Property, & Equipment, net	0.61	1.03	0.93	0.93	1.24	1.23	1.24	1.48	1.41	1.39	1.52
Total Noncurrent Assets	1,199	1,161	1,151	1,141	1,113	1,101	1,088	1,066	1,053	1,040	1,012
Goodwill	168	168	168	168	168	168	168	168	168	168	168
Intangible Assets	1,007	983	972	960	936	923	911	887	874	861	835
Noncurrent Deferred & Refundable Income Taxes	13	-	-	-	-	-	-	-	-	0.82	0.00
Other Noncurrent Operating Assets	10	10	11	12	8.42	9.37	8.43	10	11	9.70	9.25
Total Liabilities & Shareholders' Equity	1,697	1,726	1,723	1,742	1,753	1,757	1,759	1,771	1,517	1,514	1,460
Total Liabilities	953	919	905	902	898	893	879	893	643	625	582
Total Current Liabilities	89	58	61	56	60	71	57	66	120	114	71
Accounts Payable	40	26	14	13	17	23	11	24	25	23	29
Accrued Expenses	26	20	25	17	18	23	20	23	83	80	33
Current Deferred & Payable Income Tax Liabilities	16	5.80	16	2.50	4.92	5.34	5.65	12	12	10	9.21
Total Noncurrent Liabilities	864	861	844	846	838	823	823	827	523	512	511
Long-Term Debt	656	653	652	650	648	646	645	642	352	352	352
Noncurrent Deferred & Payable Income Tax Liabilities	-	2.30	2.75	4.07	2.68	2.14	3.64	5.07	3.36	0.00	0.93
Other Noncurrent Operating Liabilities	-	-	189	191	188	174	174	180	168	160	158
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	744	807	818	840	856	863	880	878	874	889	878
Total Preferred & Common Equity	744	807	818	840	856	863	880	878	874	889	878
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	744	807	818	840	856	863	880	878	874	889	878
Common Stock	311	319	322	325	321	323	326	333	336	339	347
Retained Earnings	431	486	492	512	534	540	555	546	539	550	531
Accumulated Other Comprehensive Income / (Loss)	1.93	2.02	3.67	2.81	1.00	-0.08	-0.99	-0.75	-0.63	-0.49	-0.20

This table displays calculated financial ratios and metrics derived from Olaplex's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	667,511,905.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	667,511,905.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-0.01
Growth Metrics	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	72	268	291	87	49	4.87
Return On Investment Capital (ROIC_SIMPLE)	-	-	20.18%	5.79%	3.18%	0.40%
Earnings before Interest and Taxes (EBIT)	86	337	365	116	61	20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	178	389	416	168	116	78
Valuation Ratios	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	242	492	173	144	31
Efficiency Ratios	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	1,295	1,321	1,121	1,034	939	913
Increase / (Decrease) in Invested Capital	0.00	26	-200	-87	-95	-26
Book Value per Share	$0.84	$0.81	$1.20	$1.29	$1.32	$1.32
Tangible Book Value per Share	($1.15)	($1.06)	($0.59)	($0.41)	($0.29)	($0.20)
Total Capital	1,306	1,283	1,444	1,501	1,525	1,232
Total Debt	775	758	663	656	650	352
Total Long-Term Debt	755	738	654	649	644	352
Net Debt	765	572	340	189	64	34
Capital Expenditures (CapEx)	0.03	0.88	0.65	0.38	1.12	0.33
Debt-free, Cash-free Net Working Capital (DFCFNWC)	24	96	153	97	46	49
Debt-free Net Working Capital (DFNWC)	35	282	476	564	632	368
Net Working Capital (NWC)	15	262	467	557	625	368
Net Nonoperating Expense (NNE)	32	47	47	25	29	14
Net Nonoperating Obligations (NNO)	765	797	340	189	64	34
Total Depreciation and Amortization (D&A)	92	52	51	52	55	58
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.38	$0.09	$0.03	($0.01)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	649.09M	654.59M	661.98M	666.46M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.35	$0.09	$0.03	($0.01)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	691.01M	677.58M	665.40M	666.46M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	651.90M	660.76M	664.62M	669.40M
Normalized Net Operating Profit after Tax (NOPAT)	85	268	291	87	49	4.87
Debt Service Ratios	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Olaplex's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	667,511,905.00	669,402,641.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	667,511,905.00	669,402,641.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-0.02	-0.01
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-29.98%	-14.54%	-13.08%	-4.85%	-3.62%	-9.82%	-1.95%	2.25%	-3.78%	-	2.47%
EBITDA Growth	-50.85%	-38.04%	-32.39%	-4.43%	-13.65%	-70.75%	-31.36%	-46.53%	-34.97%	-	-62.85%
EBIT Growth	-58.62%	-49.52%	-47.86%	-11.81%	-19.85%	-108.55%	-53.65%	-101.36%	-52.20%	-	-160.70%
NOPAT Growth	-59.85%	-63.46%	-50.34%	-15.63%	-26.06%	-84.81%	-69.47%	-106.88%	-74.61%	-	-179.97%
Net Income Growth	-66.48%	-58.07%	-63.05%	-6.12%	-27.34%	-162.41%	-94.00%	-233.97%	-24.80%	-	-1,236.99%
EPS Growth	-66.67%	-50.00%	-66.67%	0.00%	-33.33%	-150.00%	-100.00%	-200.00%	0.00%	-	0.00%
Operating Cash Flow Growth	-0.64%	-33.30%	-9.11%	-39.84%	-37.35%	1.27%	-106.67%	28.70%	-76.09%	-	357.08%
Free Cash Flow Firm Growth	1,074.33%	-57.85%	402.26%	-62.38%	-70.48%	-3.02%	-80.76%	-30.18%	-54.75%	-	-36.10%
Invested Capital Growth	-21.80%	-7.72%	-23.03%	-8.14%	-7.04%	-9.23%	-5.59%	-7.12%	-3.85%	-	-4.47%
Revenue Q/Q Growth	13.10%	-9.58%	-11.47%	5.09%	14.56%	-15.40%	-3.74%	9.60%	7.80%	-	-5.47%
EBITDA Q/Q Growth	58.97%	-20.51%	-16.44%	-9.49%	43.64%	-73.07%	96.08%	-29.49%	74.68%	-	-31.10%
EBIT Q/Q Growth	96.97%	-26.99%	-28.51%	-14.23%	79.01%	-107.79%	487.72%	-102.51%	6,413.82%	-	-191.67%
NOPAT Q/Q Growth	96.24%	-50.76%	4.44%	-16.41%	71.99%	-89.88%	109.89%	-118.84%	734.78%	-	-13.48%
Net Income Q/Q Growth	230.83%	-30.76%	-45.07%	-25.39%	156.05%	-159.47%	105.28%	-1,764.95%	243.72%	-	59.65%
EPS Q/Q Growth	200.00%	-33.33%	-50.00%	0.00%	100.00%	-150.00%	100.00%	0.00%	300.00%	-	50.00%
Operating Cash Flow Q/Q Growth	97.83%	-8.19%	-10.87%	-62.84%	106.02%	48.41%	-105.87%	816.63%	-61.72%	-	-77.05%
Free Cash Flow Firm Q/Q Growth	20.78%	-69.15%	212.80%	-67.72%	-5.23%	1.34%	-37.94%	17.15%	-38.57%	-	69.73%
Invested Capital Q/Q Growth	-2.73%	-3.14%	-3.06%	0.58%	-1.57%	-5.42%	0.82%	-1.04%	1.89%	-	-0.95%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	67.62%	68.73%	72.13%	69.69%	68.64%	66.28%	69.45%	71.16%	69.12%	-	72.12%
EBITDA Margin	39.90%	35.08%	33.11%	28.52%	35.75%	11.38%	23.18%	14.91%	24.16%	-	8.41%
Operating Margin	29.73%	15.36%	19.83%	15.66%	23.51%	3.02%	8.74%	-1.13%	3.65%	-	-5.14%
EBIT Margin	28.95%	23.38%	18.88%	15.41%	24.07%	-2.22%	8.92%	-0.20%	11.96%	-	-5.29%
Profit (Net Income) Margin	16.48%	12.62%	7.83%	5.56%	12.43%	-8.74%	0.48%	-7.28%	9.71%	-	-5.32%
Tax Burden Percent	77.56%	81.75%	74.70%	75.26%	75.26%	81.50%	52.78%	85.41%	127.90%	-	54.60%
Interest Burden Percent	73.41%	66.05%	55.54%	47.95%	68.59%	483.74%	10.18%	4,177.42%	63.50%	-	184.33%
Effective Tax Rate	22.44%	18.25%	25.30%	24.74%	24.74%	0.00%	47.22%	0.00%	-27.90%	-	0.00%
Return on Invested Capital (ROIC)	9.05%	5.34%	5.70%	4.90%	7.45%	0.91%	1.99%	-0.34%	2.01%	-	-1.65%
ROIC Less NNEP Spread (ROIC-NNEP)	7.13%	5.37%	3.55%	1.86%	3.76%	-7.71%	-1.73%	-6.99%	8.47%	-	-5.27%
Return on Net Nonoperating Assets (RNNOA)	3.82%	1.75%	1.37%	0.47%	0.74%	-1.14%	-0.22%	-0.84%	0.86%	-	-0.28%
Return on Equity (ROE)	12.87%	7.09%	7.07%	5.37%	8.19%	-0.23%	1.78%	-1.18%	2.86%	-	-1.94%
Cash Return on Invested Capital (CROIC)	33.61%	16.10%	32.29%	15.13%	13.37%	14.60%	9.78%	-0.03%	4.97%	-	4.07%
Operating Return on Assets (OROA)	8.04%	6.23%	4.81%	3.88%	5.96%	-0.53%	2.13%	-0.05%	3.06%	-	-1.39%
Return on Assets (ROA)	4.58%	3.37%	2.00%	1.40%	3.08%	-2.10%	0.11%	-1.88%	2.48%	-	-1.40%
Return on Common Equity (ROCE)	12.87%	7.09%	7.07%	5.37%	8.19%	-0.23%	1.78%	-1.18%	2.86%	-	-1.94%
Return on Equity Simple (ROE_SIMPLE)	9.65%	0.00%	5.65%	5.56%	4.82%	0.00%	1.39%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	28	14	15	12	21	2.13	4.47	-0.84	5.35	-3.15	-3.58
NOPAT Margin	23.06%	12.56%	14.82%	11.79%	17.69%	2.12%	4.61%	-0.79%	4.67%	-	-3.60%
Net Nonoperating Expense Percent (NNEP)	1.91%	-0.03%	2.15%	3.04%	3.68%	8.61%	3.73%	6.64%	-6.47%	-	3.62%
Return On Investment Capital (ROIC_SIMPLE)	-	0.94%	-	-	-	0.14%	0.29%	-0.07%	0.43%	-0.26%	-0.29%
Cost of Revenue to Revenue	32.38%	31.27%	27.87%	30.31%	31.36%	33.72%	30.55%	28.84%	30.88%	-	27.89%
SG&A Expenses to Revenue	29.49%	44.01%	40.88%	43.70%	36.07%	52.48%	49.48%	62.01%	55.95%	-	66.37%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Operating Expenses to Revenue	37.89%	53.36%	52.30%	54.03%	45.13%	63.26%	60.71%	72.30%	65.47%	-	77.26%
Earnings before Interest and Taxes (EBIT)	36	26	19	16	29	-2.23	8.65	-0.22	14	-1.80	-5.25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	49	39	33	30	43	11	22	16	28	12	8.35
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.52	1.97	1.48	1.18	1.77	1.31	0.96	1.07	0.98	-	1.55
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Price to Revenue (P/Rev)	2.67	3.63	2.86	2.33	3.59	2.71	2.01	2.20	2.09	-	3.19
Price to Earnings (P/E)	15.74	27.00	26.23	21.24	36.67	58.75	68.95	0.00	0.00	-	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Earnings Yield	6.35%	3.70%	3.81%	4.71%	2.73%	1.70%	1.45%	0.00%	0.00%	-	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.41	1.79	1.41	1.15	1.68	1.29	0.96	1.06	0.98	-	1.53
Enterprise Value to Revenue (EV/Rev)	3.15	4.04	3.19	2.66	3.85	2.87	2.17	2.35	2.24	-	3.26
Enterprise Value to EBITDA (EV/EBITDA)	7.83	11.03	9.30	7.72	11.58	10.40	8.59	10.77	12.13	-	21.64
Enterprise Value to EBIT (EV/EBIT)	10.63	15.99	14.34	12.06	18.65	19.82	17.85	28.53	47.20	-	215.43
Enterprise Value to NOPAT (EV/NOPAT)	13.52	21.32	19.61	16.63	26.67	24.95	23.27	0.00	92.57	-	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	7.45	10.43	8.18	7.17	11.71	8.47	9.46	9.84	12.42	-	20.05
Enterprise Value to Free Cash Flow (EV/FCFF)	3.68	10.68	3.80	7.31	12.11	8.41	9.58	0.00	19.42	-	36.82
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.78	0.78	0.76	0.76	0.74	0.74	0.74	0.40	0.40	-	0.40
Long-Term Debt to Equity	0.77	0.77	0.76	0.75	0.73	0.74	0.73	0.40	0.40	-	0.40
Financial Leverage	0.54	0.33	0.39	0.25	0.20	0.15	0.12	0.12	0.10	-	0.05
Leverage Ratio	2.17	2.11	2.09	2.07	2.04	2.04	2.03	1.88	1.85	-	1.84
Compound Leverage Factor	1.59	1.40	1.16	0.99	1.40	9.87	0.21	78.71	1.18	-	3.39
Debt to Total Capital	43.88%	43.70%	43.34%	43.07%	42.56%	42.66%	42.50%	28.70%	28.38%	-	28.65%
Short-Term Debt to Total Capital	0.45%	0.45%	0.45%	0.45%	0.44%	0.44%	0.44%	0.00%	0.00%	-	0.00%
Long-Term Debt to Total Capital	43.43%	43.25%	42.89%	42.62%	42.12%	42.21%	42.06%	28.70%	28.38%	-	28.65%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Common Equity to Total Capital	56.12%	56.30%	56.66%	56.93%	57.44%	57.34%	57.50%	71.30%	71.62%	-	71.35%
Debt to EBITDA	3.42	3.90	4.30	4.33	4.52	5.59	6.11	3.81	4.54	-	5.51
Net Debt to EBITDA	1.18	1.13	0.97	0.96	0.78	0.55	0.64	0.68	0.85	-	0.41
Long-Term Debt to EBITDA	3.39	3.86	4.25	4.28	4.47	5.53	6.05	3.81	4.54	-	5.51
Debt to NOPAT	5.91	7.55	9.07	9.33	10.42	13.40	16.56	-4.88	34.69	-	-75.88
Net Debt to NOPAT	2.04	2.18	2.04	2.07	1.81	1.33	1.74	-0.87	6.47	-	-5.67
Long-Term Debt to NOPAT	5.84	7.47	8.97	9.23	10.31	13.26	16.39	-4.88	34.69	-	-75.88
Altman Z-Score	1.98	2.23	1.96	1.79	2.22	1.86	1.69	1.92	1.94	-	2.50
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	10.69	10.92	10.71	9.27	11.84	10.67	10.74	3.86	4.16	-	6.27
Quick Ratio	8.57	9.04	8.93	7.67	10.14	9.29	9.22	2.68	2.96	-	5.11
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	326	101	315	102	96	98	61	71	44	23	39
Operating Cash Flow to CapEx	48,117.12%	36,055.15%	9,691.13%	15,038.89%	25,542.75%	11,441.94%	-6,077.08%	20,295.15%	11,270.42%	-	5,136.30%
Free Cash Flow to Firm to Interest Expense	22.20	6.86	21.70	6.96	6.17	6.56	4.41	5.73	5.67	-	5.43
Operating Cash Flow to Interest Expense	3.64	3.34	3.01	1.11	2.14	3.34	-0.21	1.69	1.04	-	1.05
Operating Cash Flow Less CapEx to Interest Expense	3.63	3.33	2.98	1.11	2.14	3.31	-0.22	1.68	1.03	-	1.03
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.28	0.27	0.25	0.25	0.25	0.24	0.24	0.26	0.26	-	0.26
Accounts Receivable Turnover	6.58	10.52	12.43	10.40	10.00	15.13	16.95	12.70	9.89	-	13.87
Inventory Turnover	1.09	1.16	1.18	1.17	1.32	1.52	1.52	1.47	1.63	-	1.75
Fixed Asset Turnover	618.67	466.70	391.19	406.23	400.23	356.38	309.48	321.37	318.56	-	284.14
Accounts Payable Turnover	5.41	16.61	6.25	7.31	10.63	14.90	6.37	5.47	7.44	-	4.76
Days Sales Outstanding (DSO)	55.50	34.70	29.35	35.10	36.51	24.12	21.53	28.74	36.89	-	26.31
Days Inventory Outstanding (DIO)	336.13	314.05	308.11	311.39	276.03	239.48	239.53	247.54	224.10	-	208.49
Days Payable Outstanding (DPO)	67.51	21.98	58.43	49.96	34.32	24.49	57.26	66.69	49.07	-	76.66
Cash Conversion Cycle (CCC)	324.13	326.78	279.04	296.54	278.22	239.11	203.79	209.59	211.92	-	158.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,068	1,034	1,003	1,009	993	939	947	937	954	913	904
Invested Capital Turnover	0.39	0.43	0.38	0.42	0.42	0.43	0.43	0.44	0.43	-	0.46
Increase / (Decrease) in Invested Capital	-298	-87	-300	-89	-75	-95	-56	-72	-38	-26	-42
Enterprise Value (EV)	1,504	1,852	1,416	1,164	1,669	1,211	912	995	940	-	1,385
Market Capitalization	1,277	1,663	1,269	1,019	1,556	1,147	844	932	874	-	1,359
Book Value per Share	$1.28	$1.29	$1.30	$1.30	$1.33	$1.32	$1.32	$1.31	$1.33	$1.32	$1.31
Tangible Book Value per Share	($0.44)	($0.41)	($0.38)	($0.35)	($0.30)	($0.29)	($0.27)	($0.25)	($0.21)	($0.20)	($0.19)
Total Capital	1,497	1,501	1,510	1,516	1,532	1,525	1,527	1,226	1,241	1,232	1,230
Total Debt	657	656	654	653	652	650	649	352	352	352	352
Total Long-Term Debt	650	649	648	646	645	644	642	352	352	352	352
Net Debt	228	189	147	145	113	64	68	63	66	34	26
Capital Expenditures (CapEx)	0.11	0.14	0.45	0.11	0.13	0.43	0.05	0.10	0.07	0.11	0.15
Debt-free, Cash-free Net Working Capital (DFCFNWC)	122	97	79	83	81	46	64	53	73	49	49
Debt-free Net Working Capital (DFNWC)	551	564	587	591	620	632	645	343	360	368	375
Net Working Capital (NWC)	544	557	580	584	613	625	638	343	360	368	375
Net Nonoperating Expense (NNE)	8.13	-0.07	6.91	6.47	6.27	11	4.01	6.90	-5.78	9.95	1.71
Net Nonoperating Obligations (NNO)	228	189	147	145	113	64	68	63	66	34	26
Total Depreciation and Amortization (D&A)	14	13	14	14	14	14	14	16	14	14	14
Debt-free, Cash-free Net Working Capital to Revenue	25.48%	21.25%	17.82%	18.87%	18.70%	10.85%	15.25%	12.62%	17.48%	-	11.51%
Debt-free Net Working Capital to Revenue	115.48%	123.02%	132.27%	134.80%	142.95%	149.48%	153.31%	81.01%	85.90%	-	88.19%
Net Working Capital to Revenue	114.07%	121.55%	130.75%	133.26%	141.39%	147.88%	151.71%	81.01%	85.90%	-	88.19%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)	$0.00	($0.01)	$0.02	($0.02)	($0.01)
Adjusted Weighted Average Basic Shares Outstanding	654.70M	654.59M	660.82M	661.73M	662.25M	661.98M	664.69M	665.95M	667.07M	666.46M	669.94M
Adjusted Diluted Earnings per Share	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)	$0.00	($0.01)	$0.02	($0.02)	($0.01)
Adjusted Weighted Average Diluted Shares Outstanding	678.76M	677.58M	663.57M	663.55M	666.15M	665.40M	666.46M	665.95M	668.86M	666.46M	669.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	654.73M	660.76M	661.76M	661.98M	662.92M	664.62M	665.92M	667.08M	667.51M	669.40M	672.04M
Normalized Net Operating Profit after Tax (NOPAT)	28	14	15	12	21	2.13	4.47	-0.84	2.93	-3.15	-3.58
Normalized NOPAT Margin	23.06%	12.56%	14.82%	11.79%	17.69%	2.12%	4.61%	-0.79%	2.56%	-	-3.60%
Pre Tax Income Margin	21.25%	15.44%	10.48%	7.39%	16.51%	-10.72%	0.91%	-8.53%	7.59%	-	-9.74%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.43	1.78	1.29	1.10	1.84	-0.15	0.63	-0.02	1.78	-	-0.74
NOPAT to Interest Expense	1.94	0.96	1.01	0.84	1.35	0.14	0.33	-0.07	0.70	-	-0.50
EBIT Less CapEx to Interest Expense	2.43	1.77	1.26	1.09	1.83	-0.18	0.63	-0.03	1.77	-	-0.76
NOPAT Less CapEx to Interest Expense	1.93	0.95	0.98	0.83	1.34	0.11	0.32	-0.08	0.69	-	-0.52
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise, investor-focused read on Olaplex (OLPX) using the last four years of quarterly data available. The focus is on trends in revenue, profitability, cash flow, and the balance sheet to help gauge growth, liquidity, and leverage.

Revenue growth in 2025: 2025 quarters show rising operating revenue from about $97.0M in Q1 to roughly $114.6M in Q3, before a dip to about $105.1M in Q4, indicating a solid growth trajectory through mid-2025.
Gross margin remains strong: 2025 gross margin stays in the ~69%–71% range across quarters, supporting profitability potential even as revenue grows.
Operating cash flow improving in 2025: Net cash from continuing operating activities improves over the year, with Q4 2025 posting about $32.7M, after roughly $20–21M in earlier quarters, signaling stronger cash generation.
Positive quarterly net income in mid-2025: Net income from continuing operations turned positive in Q3 2025 (about $11.1M), with smaller positive prints in Q1 2025, suggesting improving profitability dynamics.
Balance sheet supports liquidity: Equity base stayed robust, with Total Common Equity around $0.87B–$0.89B in mid-2025, and overall equity persisting at elevated levels, indicating a solid capital base.
Diluted EPS showing early profitability signs: Q3 2025 diluted earnings per share reached about $0.02, a positive signal on a per-share basis amid other volatility.

Investing cash flows are consistently negative: Across 2022–2025, cash used for investing activities (capex and acquisitions) remains negative, reflecting ongoing reinvestment typical for growth-oriented cosmetics brands.
Non-cash adjustments and depreciation/amortization: Large non-cash adjustments and high amortization/depreciation create sizable NI adjustments, making quarterly earnings less reflective of cash performance.

Net income volatility persists: Quarterly NI swings, including a Q4 2025 net loss of about $13.1M, show ongoing earnings volatility despite positive mid-year prints.
Leverage risk exists: Long-term debt around $0.35B–$0.36B against equity near $0.87B–$0.89B and assets around $1.5B+ implies a meaningful debt load; profitability and cash flow would need to stay strong to maintain comfortable leverage if revenue slows.

05/19/26 03:57 PM ETAI Generated. May Contain Errors.

Olaplex Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Olaplex's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Olaplex's net income appears to be on a downward trend, with a most recent value of -$9.25 million in 2025, falling from $39.28 million in 2020. The previous period was $19.52 million in 2024. Check out Olaplex's forecast to explore projected trends and price targets.

Olaplex's total operating income in 2025 was $6.95 million, based on the following breakdown:

Total Gross Profit: $293.65 million
Total Operating Expenses: $286.70 million

Over the last 5 years, Olaplex's total revenue changed from $282.25 million in 2020 to $422.96 million in 2025, a change of 49.9%.

Olaplex's total liabilities were at $618.10 million at the end of 2025, a 30.8% decrease from 2024, and a 22.9% decrease since 2020.

In the past 5 years, Olaplex's cash and equivalents has ranged from $10.96 million in 2020 to $585.97 million in 2024, and is currently $318.73 million as of their latest financial filing in 2025.

Over the last 5 years, Olaplex's book value per share changed from 0.84 in 2020 to 1.32 in 2025, a change of 57.7%.

Related Companies

Financial statements for NASDAQ:OLPX last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Olaplex (OLPX) Financials

Financials Breakdown Chart

Key Financial Trends

Olaplex Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Olaplex (OLPX) Financials

Annual Income Statements for Olaplex

Quarterly Income Statements for Olaplex

Annual Cash Flow Statements for Olaplex

Quarterly Cash Flow Statements for Olaplex

Annual Balance Sheets for Olaplex

Quarterly Balance Sheets for Olaplex

Annual Metrics And Ratios for Olaplex

Quarterly Metrics And Ratios for Olaplex

Financials Breakdown Chart

Key Financial Trends

Olaplex Financials - Frequently Asked Questions

When does Olaplex's financial year end?

How has Olaplex's net income changed over the last 5 years?

What is Olaplex's operating income?

How has Olaplex's revenue changed over the last 5 years?

How much debt does Olaplex have?

How much cash does Olaplex have?

How has Olaplex's book value per share changed over the last 5 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools